MedPath

CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.chu-dijon.fr

Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the Retina for Age-related Macular Degeneration (AMD)

Completed
Conditions
Age-related Macular Degeneration
Interventions
Biological: blood sampling
Biological: faecal sampling (optional)
First Posted Date
2020-02-20
Last Posted Date
2020-11-24
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
205
Registration Number
NCT04278300
Locations
🇫🇷

CHU dijon Bourgogne, Dijon, France

Diabetes Screening in Patients on Long-Term Glucocorticoid Therapy

Recruiting
Conditions
Glucocorticosteroid
Diabetes
Interventions
Diagnostic Test: Blood sampling
First Posted Date
2020-02-06
Last Posted Date
2024-01-12
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
75
Registration Number
NCT04258293
Locations
🇫🇷

CHU Dijon Bourgogne, Dijon, France

Interest of a Period of Fasting Before Extubation in Resuscitation Patients

Completed
Conditions
Extubation
Intensive Care
Interventions
Other: gastric ultrasound
First Posted Date
2020-01-29
Last Posted Date
2021-03-26
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
101
Registration Number
NCT04245878
Locations
🇫🇷

Chu Dijon Bourgogne, Dijon, France

Medical-economic Evaluation Comparing Intensive Outpatient Monitoring of Neuro-cardiovascular Diseases by Nurses, Doctors and Hospital and Private-sector Pharmacists, Compared to Usual Monitoring.

Recruiting
Conditions
Cerebrovascular Accidents
Myocardial Infarction
Interventions
Other: Usual follow-up
Other: Intensive follow-up
First Posted Date
2019-12-06
Last Posted Date
2023-09-21
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
1720
Registration Number
NCT04188457
Locations
🇫🇷

Chu Dijon Bourgogne, Dijon, France

A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer

Phase 3
Recruiting
Conditions
Metastatic Colorectal Cancer
Interventions
Drug: Fluoropyrimidine
First Posted Date
2019-12-05
Last Posted Date
2021-10-28
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
400
Registration Number
NCT04188145
Locations
🇫🇷

Chu Dijon Bourgogne, Dijon, France

Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS

Phase 3
Terminated
Conditions
Acute Decompensated Heart Failure
Interventions
Drug: Cernevit
First Posted Date
2019-11-12
Last Posted Date
2024-10-01
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
82
Registration Number
NCT04158674
Locations
🇫🇷

CHU Dijon Bourgogne, Dijon, France

Study of the Psychological Profile of Type 2 Diabetic Patients With Foot Wounds, Compared to Diabetic Patients Without Foot Wounds

Completed
Conditions
Type 2 Diabetes
Foot Wound
Interventions
Other: questionnaire
First Posted Date
2019-11-12
Last Posted Date
2023-02-23
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
66
Registration Number
NCT04159922
Locations
🇫🇷

Chu Dijon Bourogne, Dijon, France

Frequency of Correct Response and Factors Associated in the Medium Term With a Multimodal Rehabilitation Program for Chronic Low Back Pain

Terminated
Conditions
Chronic Low-back Pain
First Posted Date
2019-10-16
Last Posted Date
2023-10-16
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
2
Registration Number
NCT04128098
Locations
🇫🇷

CHU Dijon Bourgogne, Dijon, France

Clinical Relevance of the Reverse Lipopolysaccharide Transport Pathway in Patients With Acute Peritonitis

Completed
Conditions
Peritonitis
Interventions
Biological: blood samples
First Posted Date
2019-10-15
Last Posted Date
2023-08-29
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
27
Registration Number
NCT04126577
Locations
🇫🇷

Chu Dijon Bourogne, Dijon, France

Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming

Not Applicable
Recruiting
Conditions
Pathological Use of Internet Games
Interventions
Device: Active tDCS
Device: Placebo tDCS
Other: Questionnaires
First Posted Date
2019-10-09
Last Posted Date
2024-08-23
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Target Recruit Count
50
Registration Number
NCT04120714
Locations
🇫🇷

CHU de DIJON, Dijon, France

© Copyright 2025. All Rights Reserved by MedPath